Is Your Genome Uniform? Understanding Cellular Lineage Variation
In short: Mosaicism describes a state where different cells within one body possess distinct genetic blueprints. This variation can arise from errors occurring at various stages, from the earliest embryonic moments to later in life. Understanding the source and scope of these differences is key to understanding the body's complexity.
Mosaicism fundamentally means that an organism or tissue contains cells with different genomes, even though all cells originated from a single fertilized zygote. This contrasts with chimerism, where cells derive from multiple distinct fertilized zygotes. The genomic difference can range from a single nucleotide variant to the duplication of an entire haploid chromosome set, such as triploid D. Mosaicism can manifest due to a genomic error occurring after fertilization, during very early embryo development, or even later in development, and it is not always associated with illness.
The timing of the genetic error dictates the pattern of mosaicism. If the variant arises during embryonic development, it can potentially affect many parts of the body. Conversely, errors occurring later in life tend to be localized to specific areas. For instance, many cancers result from DNA changes that initially affect only a few cells in a localized region before those cells proliferate.
The distinction between somatic and germline mosaicism is crucial. Somatic mosaicism involves variants in body tissues and is generally not inheritable because it typically does not affect germ cells. Germline mosaicism, a rarer occurrence, happens when a variant appears in a germ cell precursor, meaning it is confined to a subset of the individual's sperm or egg cells. In this case, whether the variant is passed on to offspring is uncertain.
Historically, Alfred Sturtevant studied this in *Drosophila* in 1929. Later, H. J. Muller in 1930 linked *Drosophila* mosaicism to chromosomal rearrangements. CW Cotterman used the term somatic mosaicism in 1956 during his work on antigenic variation. In a clinical context, prenatal chromosomal microarray (CMA) testing has been used to identify mosaicism, such as a reported mosaic 3.6-Mb terminal loss in 13q34, demonstrating the utility of conventional analysis following abnormal CMA results.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Mosaicism — Knowledge Hub
- Also: Mosaic (genetics)
- Also: A Rare Finding of Mosaic 45,XX,der(13;21)(q10;q10)[15]/46,XX,r(13)(p11.2q33) Following Abnormal Prenatal Chromosomal Microarray Testing.
To cite this card, link to https://intellectplus.co.uk/app/health-mosaic-genetics.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Anatomy and morphology · More in Health · Latest · A–Z · All topics